Sensex 26638.11 77.96 0.29%
Nifty 7954.35 18.3 0.23%
Drug maker Cipla has reduced the prices on three anti-cancer drugs Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.
Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.
India Infoline News Service / 08:59, Aug 25, 2014
The outlook is a flat start. The BankNifty has given a breakout but many of the large caps are remaining in a range keeping the main indices under pressure.